2013 Neurofibromatosis Research Highlights
- Characterization of an NF2 Model that Develops Intracranial Vestibular Schwannomas and Meningiomas Associated with Hearing Loss
- MEK Inhibition Prevents Brain Abnormalities Associated with NF1
- MEK Inhibition Exhibits Efficacy in Human and Mouse Neurofibromatosis Tumors
- Mouse Model of Schwannomatosis-Related Neuropathic Pain